Figure 1

Daniel F Hayes is the Stuart B Padnos Professor of Breast Cancer Research and co-Director of the Breast Oncology Program at the University of Michigan Comprehensive Cancer Center. His research interests are in clinical and translational breast cancer research regarding new drug development, clinical trials and the development of biomarkers. Dr Hayes and colleagues published the first reports concerning the development of the CA15-3 blood test, used to evaluate patients with breast cancer. He has expertise in the use of this and other tumor markers, such as HER-2, circulating tumor cells and pharmacogenomics.